SCHEMBL12427175

SCHEMBL12427175

CCCCSc1ccc2ccccc2c1C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 6/20 0.47
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
ALDH1A1 P00352 3/20 0.44
HPGD P15428 2/20 0.44
KDM4E B2RXH2 1/20 0.44
CYP1A2 P05177 1/20 0.44
GLA P06280 1/20 0.44
CYP2C19 P33261 1/20 0.44
HSD17B10 Q99714 1/20 0.44
GAA P10253 1/20 0.43
RECQL P46063 1/20 0.43
TLR8 Q9NR97 1/20 0.42
PPARG P37231 1/20 0.41
NCEH1 Q6PIU2 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
PTGDR2 Q9Y5Y4 1/20 0.40
CYSLTR2 Q9NS75 1/20 0.40
CYSLTR1 Q9Y271 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12427691 0.78 WDR5 (0.50) PTGS2MEN1KMT2AALDH1A1KDM4E
SCHEMBL27878863 0.78 PPARG (0.48) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL3083110 0.77 HPGD (0.53) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL28480684 0.76 HSD17B10 (0.57) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL8665132 0.75 HSD17B10 (0.55) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL2607673 0.75 TLR8 (0.50) PTGS2MEN1KMT2AALDH1A1HPGD
SCHEMBL3223372 0.75 BID (0.50) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL28687732 0.75 PTGS2 (0.44) PTGS2MEN1KMT2AALDH1A1HPGD
SCHEMBL3070521 0.74 HPGD (0.50) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL27675241 0.74 PTGS2 (0.42) PTGS2MEN1KMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120316337-A1 METHOD FOR PREPARING CHEMICAL COMPOUNDS OF INTEREST BY NUCLEOPHILIC AROMATIC SUBSTITUTION OF AROMATIC CARBOXYLIC ACID DERIVATIVES SUPPORTING AT LEAST ONE ELECTRO-ATTRACTIVE GROUP UNIVERSITE DU MAINE (FR) 2012-12-13 US disclosed
WO-2011101599-A1 METHOD FOR PREPARING CHEMICAL COMPOUNDS OF INTEREST BY AROMATIC NUCLEOPHILIC SUBSTITUTION CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2011-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120316337-A1 METHOD FOR PREPARING CHEMICAL COMPOUNDS OF INTEREST BY NUCLEOPHILIC AROMATIC SUBSTITUTION OF AROMATIC CARBOXYLIC ACID DERIVATIVES SUPPORTING AT LEAST ONE ELECTRO-ATTRACTIVE GROUP COMT, NAA15, NUDC PTGS2 4865/4885MEN1 223/4885KMT2A 650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.